Lymphomatous features of , aggresive NK cell leukaemia/lymphoma with massive necrosis, hemophagocytosis and EB virus infection

Histopathology

Volumn 37, Issue 4, 2000, Pages 363-371

  Mori, N ^a   Yamashita, Y ^a   Tsuzuki, T ^b   Nakayama, A ^a   Nakazawa, M ^c   Hasegawa, Y ^d   Kojima, H ^d   Nagasawa, T ^d  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^c Department of Surgery   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Apoptosis; EBER1; Granzyme B; Natural killer (NK) cell lymphoma; Necrosis; Perforin; TIA 1

Indexed keywords

CD16 ANTIGEN; CD2 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; GRANZYME A; LEUKOSIALIN; T LYMPHOCYTE RECEPTOR; EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN-BARR VIRUS ENCODED RNA 1; VIRUS RNA;

ADULT; APOPTOSIS; ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; ERYTHROPHAGOCYTOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LEUKEMIA; LYMPH NODE BIOPSY; LYMPHOMA; MALE; NATURAL KILLER CELL; NECROSIS; PRIORITY JOURNAL; SOUTHERN BLOTTING; VIRUS INFECTION; CHEMISTRY; GENETICS; HISTIOCYTOSIS; IMMUNOLOGY; LIVER; MIDDLE AGED; PATHOLOGY; SPLEEN; VIROLOGY;

ADULT; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; KILLER CELLS, NATURAL; LIVER; LYMPHOMA; MALE; MIDDLE AGED; NECROSIS; RNA, VIRAL; SPLEEN;

EID: 0033623152     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2000.00936.x     Document Type: Article

References (63)

1. Expression of natural killer ceil markers in non-Hodgkin's lymphomas
2. Aggressive natural killer cell leukemia/lymphoma with N901-positive surface phenotype; Evidence for the existence of a third lineage in lymphoid cells
3. CD56 (NKH1)-positive hematolymphoid malignancies: An aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity
4. Lymphoproliferative disorder of granular lymphocytes: Nine cases including one with features of CD56 (NKH-1)-positive aggressive natural killer cell leukemia
5. Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract
6. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement
7. Natural killer cell leukemia. An autopsy case
8. Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation
9. Utility of a paraffin section-reactive CD56 antibody (123C3) for characterization and diagnosis of lymphomas
10. Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity
11. Expression of perforin and granzymes in vivo: Potential diagnostic markers for activated cytotoxic cells
12. Structure and function of human perforin
13. Perforin: Structure and function
14. Aggressive natural killer cell lymphoma of the small intestine
15. Perforin and granzyme expression in cytotoxic T-cell lymphomas
16. Granzymes: Exogenous proteinases that induce target cell apoptosis
17. CD56+ putative natural killer cell lymphomas; Production of cytolytic effectors and related proteins mediating tumor cell apoptosis?
18. Non-hepatosplenic T-cell lymphoma: A subset of cytotoxic lymphomas with mucosal or skin localization
19. Hepatosplenic T-cell lymphoma; a distinct clinicopathologic entity of cytotoxic rγT-cell origin
20. Cytotoxic pretein expression in natural killer cell lymphomas and in αβ and rγ peripheral T-cell lymphomas
21. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms
22. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology
23. Natural killer-like T-cell lymphomas: Aggressive lymphomas of T-large granular lymphocytes
24. Nasal lymphomas in Peru: High incidence of T-cell immunophenotype and Epstein-Barr virus infection
25. Discordant reaction of Leu4 and rabbit anti-human CD3(ε) in sinonasal T-cell lymphoma
26. Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus
27. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas
28. Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections
29. TCR-CD56+ CD2+ nasal lymphomas with membrane-localized CD3 positivity: Are the CD3+ cells neoplastic or reactive?
30. Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese
31. Fulminant clonal expansion of large granular lymphocytes. Characterization of their morphology, phenotype, genotype, and function
32. Leukemia of non-T lineage natural killer cells
33. Aggressive natural killer cell leukemia/lymphoma: Report of four cases and review of the literature
34. Expression of natural killer antigens in a subset of non-T, non-B lymphoma/leukemia with histiocytic features
35. Cytokine levels in aggressive natural killer cell leukemia and malignant histiocytosis
36. Hemophagocytic syndrome associated with aggressive natural killer cell leukemia
37. Epstein-Barr viral DNA in acute large granular lymphocytes (natural killer) leukemic cells
38. Aggressive natural killer cell lymphoma/leukemia. A recently recognized clinicopathologic entity
39. Large granular lymphocyte leukemia. A study of nine cases in a Chinese population
40. Non-nasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
41. Natural killer cell lymphoma/leukemia; pathology and treatment
42. Identification of del (6) (q21 q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukemia
43. Malignant histiocytosis. A report of three cases
44. An immunohistological study of follicular lymphoma, reticulum cell sarcoma, and Hodgkin's disease
45. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
46. Periodate-lysine-paraformaldehyde fixative: A new fixative for immunoelectron microscopy
47. Abundant expression of EBER-1 small nuclear RNA in nasopharyngeal carcinoma: A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed, paraffin-embedded carcinoma specimens
48. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues
49. Epstein-Barr virus latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma: Correlation of lymphoma phenotype with three distinct patterns of viral latency
50. Epstein-Barr virus in adult T-cell leukemia/lymphoma
51. Analysis and cloning of eukaryotic genomic DNA
52. Large granular lymphocytic leukemia. Report of 38 cases and review of the literature
53. Study of the major phenotype of large granular T-cell lymphoproliferative disorder
54. Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes
55. Constitutive expression of Fas ligand in large granular lymphocytic leukemia
56. Hemophagocytosis as a para-neoplastic syndrome in NK cell leukemia
57. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
58. Classification of natural killer (NK) cell and NK-like T-cell malignancies
59. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas
60. A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma
61. Hemophagocytic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement
62. An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand
63. Fas ligand in human serum